Pharyngeal microflora disruption by antibiotics promotes airway hyperresponsiveness after respiratory syncytial virus infection

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Ni, Ke ^a   Li, Simin ^a   Xia, Qiuling ^a   Zang, Na ^a   Deng, Yu ^b   Xie, Xiaohong ^b   Luo, Zhengxiu ^b   Luo, Yan ^a   Wang, Lijia ^a   Fu, Zhou ^b   Liu, Enmei ^b  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b CHILDREN S HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; MESSENGER RNA; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL CLEARANCE; BAGG ALBINO MOUSE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; IMMUNE RESPONSE; INFLAMMATORY CELL; LUNG LAVAGE; MICROFLORA; MOUSE; NONHUMAN; REGULATORY T LYMPHOCYTE; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RESPIRATORY TRACT ALLERGY; STREPTOCOCCUS;

ANIMALS; ANTI-BACTERIAL AGENTS; CEFOPERAZONE; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; HYPERSENSITIVITY; LUNG; METAGENOME; MICE; MICE, INBRED BALB C; PHARYNX; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA1;

MUS; RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS; STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE;

EID: 84864390145     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0041104     Document Type: Article

References (40)

1. Henderson J, Hilliard TN, Sherriff A, Stalker D, Al Shammari N, et al. (2005) Hospitalization for RSV bronchiolitis before 12 months of age and subsequent asthma, atopy and wheeze: a longitudinal birth cohort study. Pediatr Allergy Immunol 16: 386-392.
2. Penders J, Kummeling I, Thijs C, (2011) Infant antibiotic use and wheeze and asthma risk- a systematic review and meta-analysis. Eur Respir J.
3. Bisgaard H, Hermansen MN, Buchvald F, Loland L, Halkjaer LB, et al. (2007) Childhood asthma after bacterial colonization of the airway in neonates. N Engl J Med 357: 1487-1495.
4. Spurling GK, Fonseka K, Doust J, Del Mar C, (2007) Antibiotics for bronchiolitis in children. Cochrane Database Syst Rev.
5. (2006) Diagnosis and management of bronchiolitis. Pediatrics 118: 1774-1793.
6. Steiner RW, (2004) Treating acute bronchiolitis associated with RSV. Am Fam Physician 69: 325-330.
7. Antonow JA, Hansen K, McKinstry CA, Byington CL, (1998) Sepsis evaluations in hospitalized infants with bronchiolitis. Pediatr Infect Dis J 17: 231-236.
8. Samson L, Cooke C, Macdonald N, (1999) Analysis of antibiotic use and misuse in children hospitalized with RSV infection. Paediatr Child Health 4: 195-199.
9. Nagayama Y, Tsubaki T, Nakayama S, Sawada K, Taguchi K, et al. (2007) Bacterial colonization in respiratory secretions from acute and recurrent wheezing infants and children. Pediatr Allergy Immunol 18: 110-117.
10. Zhang Q, Leong SC, McNamara PS, Mubarak A, Malley R, et al. (2011) Characterisation of regulatory T cells in nasal associated lymphoid tissue in children: relationships with pneumococcal colonization. PLoS Pathog 7: e1002175.
11. Cusi MG, Martorelli B, Di Genova G, Terrosi C, Campoccia G, et al. (2010) Age related changes in T cell mediated immune response and effector memory to Respiratory Syncytial Virus (RSV) in healthy subjects. Immun Ageing 7: 14.
12. Fulton RB, Meyerholz DK, Varga SM, (2010) Foxp3+ CD4 regulatory T cells limit pulmonary immunopathology by modulating the CD8 T cell response during respiratory syncytial virus infection. J Immunol 185: 2382-2392.
13. Lee DC, Harker JA, Tregoning JS, Atabani SF, Johansson C, et al. (2010) CD25+ natural regulatory T cells are critical in limiting innate and adaptive immunity and resolving disease following respiratory syncytial virus infection. J Virol 84: 8790-8798.
14. Peebles RS Jr, Graham BS, (2005) Pathogenesis of respiratory syncytial virus infection in the murine model. Proc Am Thorac Soc 2: 110-115.
15. Ruckwardt TJ, Bonaparte KL, Nason MC, Graham BS, (2009) Regulatory T cells promote early influx of CD8+ T cells in the lungs of respiratory syncytial virus-infected mice and diminish immunodominance disparities. J Virol 83: 3019-3028.
16. Sun DQ, Yang XQ, Wang LJ, Li X, Liu EM, et al. (2010) [Effects of ovalbumin atomization on the T lymphocyte subsets of BALB/c mice with intestinal microflora disruption]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 26: 473-476.
17. Schwarze J, Hamelmann E, Bradley KL, Takeda K, Gelfand EW, (1997) Respiratory syncytial virus infection results in airway hyperresponsiveness and enhanced airway sensitization to allergen. J Clin Invest 100: 226-233.
18. Chavez-Bueno S, Mejias A, Gomez AM, Olsen KD, Rios AM, et al. (2005) Respiratory syncytial virus-induced acute and chronic airway disease is independent of genetic background: an experimental murine model. Virol J 2: 46.
19. Schwarze J, Makela M, Cieslewicz G, Dakhama A, Lahn M, et al. (1999) Transfer of the enhancing effect of respiratory syncytial virus infection on subsequent allergic airway sensitization by T lymphocytes. J Immunol 163: 5729-5734.
20. Noverr MC, Falkowski NR, McDonald RA, McKenzie AN, Huffnagle GB, (2005) Development of allergic airway disease in mice following antibiotic therapy and fungal microbiota increase: role of host genetics, antigen, and interleukin-13. Infect Immun 73: 30-38.
21. Yu Z, Morrison M, (2004) Comparisons of different hypervariable regions of rrs genes for use in fingerprinting of microbial communities by PCR-denaturing gradient gel electrophoresis. Appl Environ Microbiol 70: 4800-4806.
22. Cangemi de Gutierrez R, Miguel de Nader O, Ruiz Holgado AP, Nader-Macias ME, (1999) Microbial flora variations in the respiratory tract of mice. Mem Inst Oswaldo Cruz 94: 701-707.
23. Stein RT, Sherrill D, Morgan WJ, Holberg CJ, Halonen M, et al. (1999) Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 354: 541-545.
24. Fjaerli HO, Farstad T, Rod G, Ufert GK, Gulbrandsen P, et al. (2005) Acute bronchiolitis in infancy as risk factor for wheezing and reduced pulmonary function by seven years in Akershus County, Norway. BMC Pediatr 5: 31.
25. Estripeaut D, Torres JP, Somers CS, Tagliabue C, Khokhar S, et al. (2008) Respiratory syncytial virus persistence in the lungs correlates with airway hyperreactivity in the mouse model. J Infect Dis 198: 1435-1443.
26. Jafri HS, Chavez-Bueno S, Mejias A, Gomez AM, Rios AM, et al. (2004) Respiratory syncytial virus induces pneumonia, cytokine response, airway obstruction, and chronic inflammatory infiltrates associated with long-term airway hyperresponsiveness in mice. J Infect Dis 189: 1856-1865.
27. Sakaguchi S, (2011) Regulatory T cells: history and perspective. Methods Mol Biol 707: 3-17.
28. Sakaguchi S, Wing K, Miyara M, (2007) Regulatory T cells- a brief history and perspective. Eur J Immunol 37: S116-123.
29. Ostman S, Rask C, Wold AE, Hultkrantz S, Telemo E, (2006) Impaired regulatory T cell function in germ-free mice. Eur J Immunol 36: 2336-2346.
30. Basset C, Thiam F, Martino CD, Holton J, Clements JD, et al. (2010) Cholera-Like Enterotoxins and Regulatory T cells. Toxins (Basel) 2: 1774-1795.
31. Scerbo MJ, Bibolini MJ, Roth GA, Monferran CG, (2012) Synapsin peptide fused to E. coli heat-labile toxin B subunit induces regulatory T cells and modulates cytokine balance in experimental autoimmune encephalomyelitis. J Neuroimmunol 242: 16-25.
32. Burchell JT, Wikstrom ME, Stumbles PA, Sly PD, Turner DJ, (2009) Attenuation of allergen-induced airway hyperresponsiveness is mediated by airway regulatory T cells. Am J Physiol Lung Cell Mol Physiol 296: L307-319.
33. Presser K, Schwinge D, Wegmann M, Huber S, Schmitt S, et al. (2008) Coexpression of TGF-beta1 and IL-10 enables regulatory T cells to completely suppress airway hyperreactivity. J Immunol 181: 7751-7758.
34. Del Prete G, De Carli M, Almerigogna F, Giudizi MG, Biagiotti R, et al. (1993) Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J Immunol 150: 353-360.
35. Letterio JJ, Roberts AB, (1998) Regulation of immune responses by TGF-beta. Annu Rev Immunol 16: 137-161.
36. Gordon ED, Sidhu SS, Wang ZE, Woodruff PG, Yuan S, et al. (2012) A protective role for periostin and TGF-beta in IgE-mediated allergy and airway hyperresponsiveness. Clin Exp Allergy 42: 144-155.
37. Alcorn JF, Rinaldi LM, Jaffe EF, van Loon M, Bates JH, et al. (2007) Transforming growth factor-beta1 suppresses airway hyperresponsiveness in allergic airway disease. Am J Respir Crit Care Med 176: 974-982.
38. Uhl EW, Castleman WL, Sorkness RL, Busse WW, Lemanske RF Jr, et al. (1996) Parainfluenza virus-induced persistence of airway inflammation, fibrosis, and dysfunction associated with TGF-beta 1 expression in brown Norway rats. Am J Respir Crit Care Med 154: 1834-1842.
39. O'Flaherty S, Saulnier DM, Pot B, Versalovic J, (2010) How can probiotics and prebiotics impact mucosal immunity? Gut Microbes 1: 293-300.
40. Bienenstock J, McDermott MR, (2005) Bronchus- and nasal-associated lymphoid tissues. Immunol Rev 206: 22-31.